Cardinal Health plans to acquire Medtronic's Patient Care, Deep Vein Thrombosis, and Nutritional Insufficiency businesses for $6.1 billion. The acquisition will expand Cardinal Health's product portfolio and presence across care settings. It is expected to be accretive to earnings per share beginning in fiscal year 2018 and generate over $150 million in annual synergies by fiscal year 2020. The acquisition will be funded with new debt and is expected to increase Cardinal Health's adjusted debt to EBITDA ratio to slightly over 2.0 times by the end of fiscal year 2020.
Staying Relevant in a High Volume, Commoditized, Medical Device Product Line ...marcus evans Network
Beth Krenzer, Cardinal Health - Speaker at the marcus evans Medical Device Manufacturing Summit Spring 2012, held in Las Vegas, NV, delivered his presentation entitled Staying Relevant in a High Volume, Commoditized, Medical Device Product Line in Manufacturing (Insourced and Outsourced)
iHT² Health IT Summit New York - Mark MacNaughton, SVP & CIO, Medial Segment at Cardinal Health - Keynote Presentation “Information as an Asset - Moving From the T Side of IT to the I”
Staying Relevant in a High Volume, Commoditized, Medical Device Product Line ...marcus evans Network
Beth Krenzer, Cardinal Health - Speaker at the marcus evans Medical Device Manufacturing Summit Spring 2012, held in Las Vegas, NV, delivered his presentation entitled Staying Relevant in a High Volume, Commoditized, Medical Device Product Line in Manufacturing (Insourced and Outsourced)
iHT² Health IT Summit New York - Mark MacNaughton, SVP & CIO, Medial Segment at Cardinal Health - Keynote Presentation “Information as an Asset - Moving From the T Side of IT to the I”
Centric Health Corporation - Investor Presentation - May 2020SharePitch
Updated investor presentation for Centric Health Corporation (TSX: CHH). Updates include the competion of the Remedy'sRx acquisition and first quarter financial results.